Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China To Finalize Draft TCM Law By Year End

This article was originally published in PharmAsia News

Executive Summary

According to China's State Administration of Traditional Chinese Medicine, drafting legislation for traditional medicine has started and is currently in the study and research phase. SATCM plans to complete the draft, submission and relevant preparations of the law by year end. China's TCM industry is still in a chaotic stage because the current regulation on the Administration of Medical Institutions and Drug Administration Law do not clearly define the rules for clinical TCM techniques, TCM granule prescription and TCM usage. Experts suggest that the law should establish the property, position, functionality and development principles for traditional medicine; specify the government's role in TCM development and administrative responsibilities for TCM authorities at all levels; and standardize organizational personnel, safety measures, education and research, as well as legal obligations. (Click here for more - Chinese Language)

You may also be interested in...



Specialists Advocate Helmet Ventilation For COVID-19 Hospital Treatment

Experts from the University of Chicago are advocating for helmet ventilation for COVID-19 patients. Medtech Insight spoke to acute nurse practitioner Aurika Savickaite who is helping lead an initiative to educate and raise awareness of the technology.

 

Global Medtech Guidance Tracker: March 2020

Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Sixty-nine guidance documents have been posted on the tracker since its last update.

AbbVie Brings In Non-EU Kaletra To Bolster Dwindling French Supplies

The US company is bringing extra supplies of lopinavir/ritonavir into France but stresses that the combination treatment is not authorized for treating patients with the coronavirus.

UsernamePublicRestriction

Register

SC071198

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel